| Dr Kyle Lark, OD | |
|
1321 Pine Ave, Alma, MI 48801-1242 | |
| (989) 463-1139 | |
| (989) 466-2808 |
| Full Name | Dr Kyle Lark |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 6 Years |
| Location | 1321 Pine Ave, Alma, Michigan |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346731163 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 4901005111 (Michigan) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| James H Seals Peter B Tacia And Tad J Bartz Od Pc | 5294854105 | 9 |
News Archive
There has been a spate of several overdoses in Georgia this week leading to four deaths according to the officials at Georgia Bureau of Investigation. The Bureau issued a statement saying that there is presence of two synthetic opioids in the fake prescription pills that led to these cases of overdose.
Stem Cell Assurance, Inc. and MDwerks, Inc. announced today a financing and marketing partnership today wherein MDwerks, through it's Xeni Finance subsidiary, has provided the first tranche of financing to Stem Cell for the purchase of various medical devices from Cytori Therapeutics, Inc.
Crealta Pharmaceuticals LLC, today announced that the Journal of Clinical Rheumatology published a comprehensive review of a post-hoc safety analysis that was completed for Krystexxa (pegloticase), including data from the two pivotal randomized Phase III trials and one open-label extension trial.
Aspyra, Inc. today announced that they have received FDA 510(k) marketing clearance for AccessNET, the Company's PACS (Picture Archive Communication System) product with the capability to view digital mammography studies for diagnostic interpretation using FDA approved monitors.
› Verified 1 days ago
| Provider Name | James H Seals Peter B Tacia & Tad J Bartz Od Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1740345701 PECOS PAC ID: 5294854105 Enrollment ID: O20110112000326 |
News Archive
There has been a spate of several overdoses in Georgia this week leading to four deaths according to the officials at Georgia Bureau of Investigation. The Bureau issued a statement saying that there is presence of two synthetic opioids in the fake prescription pills that led to these cases of overdose.
Stem Cell Assurance, Inc. and MDwerks, Inc. announced today a financing and marketing partnership today wherein MDwerks, through it's Xeni Finance subsidiary, has provided the first tranche of financing to Stem Cell for the purchase of various medical devices from Cytori Therapeutics, Inc.
Crealta Pharmaceuticals LLC, today announced that the Journal of Clinical Rheumatology published a comprehensive review of a post-hoc safety analysis that was completed for Krystexxa (pegloticase), including data from the two pivotal randomized Phase III trials and one open-label extension trial.
Aspyra, Inc. today announced that they have received FDA 510(k) marketing clearance for AccessNET, the Company's PACS (Picture Archive Communication System) product with the capability to view digital mammography studies for diagnostic interpretation using FDA approved monitors.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kyle Lark, OD 1321 Pine Ave, Alma, MI 48801-1242 Ph: (989) 463-1139 | Dr Kyle Lark, OD 1321 Pine Ave, Alma, MI 48801-1242 Ph: (989) 463-1139 |
News Archive
There has been a spate of several overdoses in Georgia this week leading to four deaths according to the officials at Georgia Bureau of Investigation. The Bureau issued a statement saying that there is presence of two synthetic opioids in the fake prescription pills that led to these cases of overdose.
Stem Cell Assurance, Inc. and MDwerks, Inc. announced today a financing and marketing partnership today wherein MDwerks, through it's Xeni Finance subsidiary, has provided the first tranche of financing to Stem Cell for the purchase of various medical devices from Cytori Therapeutics, Inc.
Crealta Pharmaceuticals LLC, today announced that the Journal of Clinical Rheumatology published a comprehensive review of a post-hoc safety analysis that was completed for Krystexxa (pegloticase), including data from the two pivotal randomized Phase III trials and one open-label extension trial.
Aspyra, Inc. today announced that they have received FDA 510(k) marketing clearance for AccessNET, the Company's PACS (Picture Archive Communication System) product with the capability to view digital mammography studies for diagnostic interpretation using FDA approved monitors.
› Verified 1 days ago
State Street Optics Optometrist Medicare: Not Enrolled in Medicare Practice Location: 322 N State St, Alma, MI 48801 Phone: 989-463-1139 | |
Mr. Jacob Zainea, OD Optometrist Medicare: May Accept Medicare Assignments Practice Location: 1321 Pine Ave, Alma, MI 48801 Phone: 989-463-1139 | |
Megan Louise Lark, OD Optometrist Medicare: May Accept Medicare Assignments Practice Location: 1321 Pine Ave, Alma, MI 48801 Phone: 989-463-1139 | |
Great Lakes Eye Institute Optometrist Medicare: Medicare Enrolled Practice Location: 623 W Warwick Dr, Suite 1, Alma, MI 48801 Phone: 989-463-1126 Fax: 989-463-6013 | |
James Seals Peter Tacia Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1321 Pine Ave, Alma, MI 48801 Phone: 989-463-1139 Fax: 989-466-2808 | |
Dr. Garrett W Whitmore, OD Optometrist Medicare: May Accept Medicare Assignments Practice Location: 1321 Pine Ave, Alma, MI 48801 Phone: 989-463-1139 Fax: 989-466-2808 |